Flavored Ready-to-Drink Alcohol Restriction in Young Adults: Behavioral and Biomarker Outcomes
1 other identifier
interventional
30
0 countries
N/A
Brief Summary
This pilot randomized behavioral study evaluates the feasibility, adherence, and acceptability of an intervention to restrict flavored ready-to-drink (RTD) alcoholic beverages among young adults who regularly use both alcohol and e-cigarettes. Participants will complete a 2-week baseline period followed by a 2-week intervention period. Participants will be randomized to either avoid flavored RTD alcoholic beverages or continue their usual alcohol consumption. Primary outcomes include feasibility, adherence, acceptability. Secondary outcomes include preliminary efficacy of flavored RTD restriction on alcohol consumption and e-cigarette use measured through daily electronic diaries; biomarkers of alcohol and nicotine exposure, including urinary ethyl glucuronide (EtG), urinary cotinine, and blood phosphatidylethanol (PEth).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2026
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 18, 2026
CompletedFirst Posted
Study publicly available on registry
September 25, 2026
CompletedStudy Start
First participant enrolled
October 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 1, 2027
September 30, 2026
September 1, 2026
5 months
September 18, 2026
September 25, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Binary indicator of study completion
The primary endpoint is a binary indicator of completion of at least 75% of study visits and 75% of surveys.
From enrollment to the end of treatment at 4 weeks
Secondary Outcomes (5)
Number of standard drinks consumed
From enrollment to the end of treatment at 4 weeks.
Number of vaping sessions
From enrollment to the end of treatment at 4 weeks.
Blood phosphatidylethanol 16:0/18:1 (PEth)
Week -2, at enrollment.
Urinary ethyl glucuronide (EtG)
Week -1, Week 0, Week 1, and Week 2 Study Visits.
Urinary cotinine concentrations
Week -1, Week 0, Week 1 and Week 2 Study Visits
Study Arms (2)
No-restriction Control Group
NO INTERVENTIONParticipants assigned to the no-restriction control group will continue their usual alcohol and e-cigarette consumption.
Restriction Group
EXPERIMENTALParticipants assigned to the restriction group will be instructed to avoid flavored ready-to-drink alcoholic beverages for 2 weeks. They will not be asked to avoid unflavored alcoholic beverages or any e-cigarettes.
Interventions
The intervention under study is a behavioral restriction of flavored RTD alcoholic beverages among young adults who regularly use alcohol and e-cigarettes. Participants randomized to the intervention group will be instructed to avoid flavored RTD alcoholic beverages for two weeks while continuing all other alcohol and e-cigarette use ad libitum. Participants randomized to the control group will continue their usual alcohol and e- cigarette use without restrictions.
Eligibility Criteria
You may qualify if:
- being between 21 and 29 years old,
- currently moderate alcohol drinking (i.e., at least 4 standard drinks per week in the past 3 months), with flavored RTD beverages comprising at least 50% of total alcohol consumption,
- current regular e-cigarette use (i.e., 20 out of 30 days every month in the past 3 months),
- English-speaking,
- access to a smartphone for diary reporting.
You may not qualify if:
- Being in current cessation treatment for substances of interest in the study,
- Having serious or unstable psychiatric or medical conditions,
- Being pregnant or breastfeeding,
- Use of other psychoactive substances unless prescribed and stable.
- Inability or unwillingness of the subject to give informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor-Faculty
Study Record Dates
First Submitted
September 18, 2026
First Posted
September 25, 2026
Study Start
October 1, 2026
Primary Completion (Estimated)
March 1, 2027
Study Completion (Estimated)
August 1, 2027
Last Updated
September 30, 2026
Record last verified: 2026-09
Data Sharing
- IPD Sharing
- Will share
De-identified individual participant data may be shared with qualified investigators for future research related to alcohol use, nicotine or e-cigarette use, substance use patterns, biomarkers of exposure, cancer prevention, or related health outcomes. Data will be shared only after appropriate institutional and IRB approvals are obtained and in accordance with the informed consent provided by participants. Direct identifiers will not be included in shared datasets.